Login Register Cart 0
Generic placeholder image

Central Nervous System Agents in Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 1871-5249
ISSN (Online): 1875-6166

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Extraction, GC-MS Evaluation and Anti-epileptic Potential of Seeds Ethanolic Extract of Putranjiva roxburghii Wall

Author(s): Chandra Kala*, Syed S. Imam, Mohamad Taleuzzaman, Sadaf J. Gilani, Syed S. Ali, Iqra Rahat, Adil Ahmad and Najam A. Khan

Volume 20, Issue 3, 2020

Page: [186 - 193] Pages: 8

DOI: 10.2174/1871524920999201027125743

Price: $65

Abstract

Background: Putranjiva roxburghii Wall is traditionally known to cure many pathological conditions including epilepsy.

Objective: The present study is aimed at determining bioactive compounds in ethanolic extract of Putranjiva roxburghii test extract (PRTE) seeds by GCMS analysis and to assess its antiepileptic potential using various experimental models of epilepsy.

Methods: The ethanolic extract of seeds of Putranjiva roxburghii was subjected to GC-MS analysis to detect the bioactive phytoconstituents. Acute oral toxicity of the extract was performed using OCED guideline 420. Pentylenetetrazol (PTZ) kindling model of epilepsy and Maximal electroshock epilepsy (MES) model of epilepsy were used to determine anti-epileptic potential.

Results: The GC-MS analysis of the extract revealed the presence of 20 phytoconstituents. The major phytoconstituents included n-Propyl heptyl ether (25.25%), 5-Ethyl hydantoin (8%), octadec- 9-enoic acid (16.25%) and 1, 2-Benzene dicarboxylic acid (11.86%). The PRTE (50 mg/kg and 100 mg/kg) afforded a significant and dose-dependent protection against PTZ-induced kindling epilepsy and MES induced epilepsy (p<0.001 and p<0.01).

Conclusion: Based on the above findings, it is evident that Putranjiva roxburghii seeds contain biologically active compounds. It can also be concluded that the extract possesses anti-epileptic potential.

Keywords: GC-MS analysis, anti-epileptic activity, Putranjiva roxburghii, 5-Ethylhydantoin, PTZ – induced kindling epilepsy, MES induced epilepsy.

« Previous Next »
Graphical Abstract

[1]
Khare CP. Indian medicinal plants an illustrated dictionary Springer: India,. 2007; pp. 528-9.
[http://dx.doi.org/10.1007/978-0-387-70638-2]
[2]
Patel GK, Kar B, Sharma AK. Characterization of a thermostable family 1 Glycosyl Hydrolase enzyme from Putranjiva roxburghii seeds. Appl Biochem Biotechnol 2012; 166(3): 523-35.
[http://dx.doi.org/10.1007/s12010-011-9445-2] [PMID: 22086564]
[3]
Asolkar LV, Kakkar KK, Charke OJ. Second supplement to glossary of Indian medicinal plants with active principles Part-I (A-K) (1965–1981). Publications and Information Directorate (CSIR): New Delhi, India, 1992.
[4]
Gupta M. A review of pharmacological properties, pharmacognosy and therapeutic actions of Putranjiva roxburghii Wall. (Putranjiva). Int J Herb 2016; 4(6): 104-8.
[5]
Shastry CS, Aswathanarayana BJ, Ganesh S, Kalluraya B, Maurya DK. Radioprotective activity of ethanolic extract of seed of Drypetes roxburgii Wall in swiss albino mice. World J Pharm Res 2014; 3(2): 2330-46.
[6]
Vandana R, Kumud U. In vitro antimicrobial activity and phytochemical screening of Drypetesroxburghii leaves extracts. Int J Res Ayurveda Pharm 2012; 3(4): 582-6.
[7]
Takuhiro UT, Hou DX, Morinaga O, Shoyama Y. Molecular mechanisms underlying anti-inflammatory actions of 6-(Methylsulfinyl) hexylIsothiocyanate derived from wasabi (Wasabia japonica). Adv Pharmacol Sci 2012; 2012: 1-8.
[http://dx.doi.org/10.1155/2012/614046]
[8]
Raghavendra HL, Prashith KT, Valleesha NC, Sudharshan S, Chinmaya A. Screening for cytotoxic activity of methanol extract of Putranjiva roxburghii Wall (Euphorbiaceae) seeds. Phcog J 2010; 2(10): 335-7.
[http://dx.doi.org/10.1016/S0975-3575(10)80105-1]
[9]
Chinmaya A, Sudharshan SJ, Valeesha NC, Kekuda TRP, Rajeshwara AN, Murtaza S. phytoconstituents and antioxidant activity of Drypetes roxburghii wall, coscinium fenestratum colebr and nardostachys jatamansi dc. Glob J Pharmacol 2009; 3(1): 53-8.
[10]
Abhimanyu KK, Ravindra CS, Avanapu RS. Data on investigation of hypoglycemic, anti-cholesteremic, in vivo antioxidant and pancreatic beta cell protective effect of Putranjiva roxburghii Wall bark in streptozotocin-induced diabetic rats. Data Brief 2018; 18: 1839-46.
[http://dx.doi.org/10.1016/j.dib.2018.04.124] [PMID: 29904686]
[11]
Brunton LL, Chabner BA, Knollmann BC. Goodman Gilman’s, The Pharmacological basis of Therapeutics. 12th ed. MacGraw Hills 2011.
[12]
Behr C, Goltzene MA, Kosmalski G, Hirsch E, Ryvlin P. Epidemiology of epilepsy. Rev Neurol (Paris) 2016; 172(1): 27-36.
[http://dx.doi.org/10.1016/j.neurol.2015.11.003] [PMID: 26754036]
[13]
Tamboli AM, Rub RA, Ghosh P, Bodhankar SL. Antiepileptic activity of lobeline isolated from the leaf of Lobelia nicotianaefolia and its effect on brain GABA level in mice. Asian Pac J Trop Biomed 2012; 2(7): 537-42.
[http://dx.doi.org/10.1016/S2221-1691(12)60092-6] [PMID: 23569966]
[14]
Hanaya R, Arita K. The new antiepileptic drugs: Their Neuropharmacology and clinical indications. Neurol Med Chir (Tokyo) 2016; 56(5): 205-20.
[http://dx.doi.org/10.2176/nmc.ra.2015-0344] [PMID: 26935782]
[15]
Alexopoulos A. Pharmacoresistant epilepsy, Definition and explanation. Epileptology 2013; 1(1): 38-42.
[http://dx.doi.org/10.1016/j.epilep.2013.01.001]
[16]
Dalkara S, Karakurt A. Recent progress in anticonvulsant drug research: strategies for anticonvulsant drug development and applications of antiepileptic drugs for non-epileptic central nervous system disorders. Curr Top Med Chem 2012; 12(9): 1033-71.
[http://dx.doi.org/10.2174/156802612800229215] [PMID: 22352861]
[17]
Liu W, Ge T, Pan Z, Leng Y, Lv J, Li B. The effects of herbal medicine on epilepsy. Oncotarget 2017; 8(29): 48385-97.
[http://dx.doi.org/10.18632/oncotarget.16801] [PMID: 28423368]
[18]
Gomathi D, Kalaiselvi M, Ravikumar G, Devaki K, Uma C. GC-MS analysis of bioactive compounds from the whole plant ethanolic extract of Evolvulus alsinoides (L.) L. J Food Sci Technol 2015; 52(2): 1212-7.
[http://dx.doi.org/10.1007/s13197-013-1105-9] [PMID: 25694742]
[19]
De S, Dey A. SudhakarBabu AMS, Aneela S. Phytochemical and GC–MS analysis of bioactive compounds of SphaeranthusamaranthoidesBurm. Pharmacogn J 2013; 5(6): 265-8.
[http://dx.doi.org/10.1016/j.phcgj.2013.09.005]
[20]
Hasan MM, Mahmud Md. MR, Islam MG. GC-MS analysis of bio-active compounds in ethanol extract of Putranjiva roxburghii Wall. Fruit Peel Pharmacogn J 2019; 11(1): 146-9.
[http://dx.doi.org/10.5530/pj.2019.1.24]
[21]
Sireeratawong S, Jaijoy K, Khonsung P, Lertprasertsuk N, Ingkaninan K. Acute and chronic toxicities of Bacopa monnieri extract in Sprague-Dawley rats. BMC Complement Altern Med 2016; 16: 249.
[http://dx.doi.org/10.1186/s12906-016-1236-4] [PMID: 27460904]
[22]
Twinomujuni SS, Oloro J, Alele PE. Anticonvulsant and anxiolytic activity of the leaf aqueous and ethanolic extracts of Melanthera scandens in a rat model. Afr J Pharm Pharmacol 2016; 10(12): 216-22.
[http://dx.doi.org/10.5897/AJPP2015.4488] [PMID: 27158431]
[23]
Viswanatha GL, Venkataranganna MV, Prasad NBL, Ashok G. Evaluation of anti-epileptic activity of leaf extracts of Punica granatum on experimental models of epilepsy in mice. J Intercult Ethnopharmacol 2016; 5(4): 415-21.
[http://dx.doi.org/10.5455/jice.20160904102857] [PMID: 27757273]
[24]
Ferrer I, Thurman E. Advanced technique in GC-MS and GC-TOF-MS for environmental chemistry. Elsevier 2013; p. 61.
[25]
Mandal SC, Mandal V, Das AK. Essential of Botanical Extraction Academic Imprints: UK,. 2015.
[26]
Aaron M, Cook AM, Bensalem-Owen MK. Mechanisms of action of antiepileptic drugs. Therapy 2011; 8(3): 307-13.
[http://dx.doi.org/10.2217/thy.11.19]
[27]
Kalueff AV. Mapping convulsants’ binding to the GABA-A receptor chloride ionophore: A proposed model for channel binding sites. Neurochem Int 2007; 50(1): 61-8.
[http://dx.doi.org/10.1016/j.neuint.2006.07.004] [PMID: 16959376]
[28]
Reddy AJ, Dubey AK, Handu SS, et al. Anticonvulsant and antioxidant effects of Musa sapientum stem extract on acute and chronic experimental models of epilepsy. Pharmacognosy Res 2018; 10(1): 49-54.
[PMID: 29568187]
[29]
Nieoczym D, Socała K, Wlaź P. Assessment of the anticonvulsant potency of ursolic acid in seizure threshold tests in mice. Neurochem Res 2018; 43(5): 995-1002.
[http://dx.doi.org/10.1007/s11064-018-2505-z] [PMID: 29541930]

Rights & Permissions Print Cite
Article Metrics
29
© 2024 Bentham Science Publishers | Privacy Policy